Form 8-K - Current report:
SEC Accession No. 0001628280-23-017028
Filing Date
2023-05-10
Accepted
2023-05-10 08:03:44
Documents
15
Period of Report
2023-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vcel-20230510.htm   iXBRL 8-K 43781
2 EX-99.1 ex991earningsreleaseq12023.htm EX-99.1 107235
6 vericellogoa26a.jpg GRAPHIC 48734
  Complete submission text file 0001628280-23-017028.txt   371995

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vcel-20230510.xsd EX-101.SCH 2521
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vcel-20230510_lab.xml EX-101.LAB 24451
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vcel-20230510_pre.xml EX-101.PRE 13054
9 EXTRACTED XBRL INSTANCE DOCUMENT vcel-20230510_htm.xml XML 10805
Mailing Address 64 SIDNEY ST. CAMBRIDGE MA 02139
Business Address 64 SIDNEY ST. CAMBRIDGE MA 02139 7349305555
Vericel Corp (Filer) CIK: 0000887359 (see all company filings)

EIN.: 943096597 | State of Incorp.: MI | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35280 | Film No.: 23904415
SIC: 2836 Biological Products, (No Diagnostic Substances)